The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study.

The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study.

Item
http://www.wikidata.org/entity/Q33403311
Polo-like kinase and its inhibitors: Ready for the match to start?Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanismsThe PLK1 inhibitor GSK461364A is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutationsRemote loading of preencapsulated drugs into stealth liposomes.Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy.Identification of Polo-like kinases as potential novel drug targets for influenza A virus.Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53.Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas.
P2860

The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study.

Item
http://www.wikidata.org/entity/Q33403311
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The Plk1 inhibitor BI 2536 in ...... single dose-escalation study.
@ast
The Plk1 inhibitor BI 2536 in ...... single dose-escalation study.
@en
type
label
The Plk1 inhibitor BI 2536 in ...... single dose-escalation study.
@ast
The Plk1 inhibitor BI 2536 in ...... single dose-escalation study.
@en
prefLabel
The Plk1 inhibitor BI 2536 in ...... single dose-escalation study.
@ast
The Plk1 inhibitor BI 2536 in ...... single dose-escalation study.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
The Plk1 inhibitor BI 2536 in ...... single dose-escalation study.
@en
P2093
P2860
P304
P31
P356
10.3109/10428194.2012.729833
P433
P478
P50
P577
P698